Key Findings
- 01Houston nerve block median rates range from $948 (Centene) to $2,700 (Humana) — a 2.8x payer spread for the identical procedure at overlapping facilities
- 02Commercial nerve block rates average 20x Medicare reimbursement, with some payer-facility combinations exceeding 40x
- 03A self-insured employer with 100 orthopedic surgeries per year faces $50,000-$150,000 in addressable nerve block savings alone
- 04Discount percentages mask rate-level overpayment: a 55% discount off $12,000 billed charges yields $5,400 — while a 40% discount off $4,000 yields $1,600
The Metric That Misleads
Every benefits broker in Texas has sat across from an employer and said some version of this: "We negotiated a 55% discount off billed charges." The employer nods. The number sounds large. The conversation moves on.
This is one of the most consequential misunderstandings in employer-sponsored healthcare. A discount percentage tells you almost nothing about what you are actually paying — and in many cases, it actively obscures the truth.
Consider surgical nerve blocks in Houston. CPT 64446 — a sciatic nerve block, commonly performed during orthopedic and lower-extremity surgeries — is a high-volume, high-dollar procedure that appears on claims across every major hospital system in the Houston metro area. Our analysis of 2,068 negotiated rate records across 6 facilities reveals what discount percentages hide.
The Discount Illusion
Hospital billed charges for nerve blocks in Houston vary enormously. A hospital might set its chargemaster price for CPT 64446 at $6,000, $8,000, or $12,000 — these numbers are largely arbitrary, bearing little relationship to cost or market value.
A 55% discount off a $12,000 billed charge produces a payment of $5,400.
A 40% discount off a $4,000 billed charge produces a payment of $1,600.
The "better" discount yields the higher price. This is not a hypothetical. It is the actual dynamic playing out in Houston nerve block pricing today.
Our data shows median negotiated rates for CPT 64446 ranging from $948 to $2,700 depending on the payer — a spread of nearly 3x for the identical clinical service at overlapping facilities:
- Humana: $2,700 median negotiated rate
- Oscar Health: $2,027
- Cigna: $1,917
- United Healthcare: $1,452
- Blue Cross Blue Shield: $1,299
- Community Health Choice: $1,206
- Aetna: $1,152
- Centene: $948
Every one of these rates could be described as a "significant discount" off billed charges. And every one of these rates is between 15 and 42 times the Medicare reimbursement for this procedure.
The 10th-percentile rate in our dataset is $376. The 90th percentile is $2,405. That is a 6.4x spread — for a procedure that does not vary in complexity, technique, or required resources based on who is paying for it.
Why This Matters for Plan Sponsors
Surgical nerve blocks are a useful case study because they sit at the intersection of three trends that are reshaping employer healthcare costs:
1. Surgical Volume Is Growing
Orthopedic surgeries — knee replacements, ACL repairs, rotator cuff procedures — are among the highest-volume, highest-cost categories for self-insured employers. Nerve blocks are a standard component of the anesthesia protocol for these surgeries. As surgical volume increases with an aging workforce, nerve block claims increase proportionally.
Our Houston data shows related nerve block codes (64446, 64447, 64448, 64449, 64415, 64416) collectively generating over 10,000 rate records across 6 facilities. This is not a niche procedure. It is a material cost driver.
2. Bundling Obscures Individual Pricing
Nerve blocks are typically billed as part of a surgical episode that includes surgeon fees, facility fees, anesthesia, implants, and post-operative care. When an employer reviews a surgical claim totaling $45,000, the $2,700 nerve block charge does not draw attention. It is lost in the aggregate.
But these charges compound. A typical orthopedic surgery involves 2-4 nerve block codes. If each is priced at the 75th percentile rather than the 25th, the nerve block component alone adds $2,000-$4,000 per surgery beyond what a well-benchmarked plan would pay.
3. The Medicare Ratio Reveals True Markup
Our data shows CPT 64446 commercial rates averaging 20x the Medicare reimbursement. The related nerve block codes (64448, 64449) show ratios of 23-24x Medicare.
Medicare rates are not perfect benchmarks — they are designed for a 65+ population and reflect political as much as economic pricing. But a 20x multiplier is not a reasonable margin over Medicare. It is a pricing structure built for a market where the buyer has no visibility into what they are paying or what alternatives exist.
The Framework: From Discounts to Rates
The employers who are taking control of their healthcare spend have abandoned discount-based thinking. They have adopted a rate-based framework that provides genuine visibility into what their plan is paying. Here is how it works:
Step 1: Identify Your Top 50 Procedures by Spend
Pull 12 months of claims data. Rank procedures by total plan spend (not just unit cost — volume matters). Nerve blocks, infusions, imaging, lab panels, and surgical codes will dominate the list. These are your high-impact targets.
Step 2: Benchmark Each Code Against Market Rates
For each of your top 50 codes, determine where your plan's negotiated rates sit on the market distribution. Are you at the 25th percentile? The 50th? The 75th? This is information your TPA should be able to provide — and if they cannot, that itself is informative.
Our data provides these benchmarks for Houston and other Texas metros. The comparison should be against actual negotiated rates in your market, not national averages or billed charge discounts.
Step 3: Calculate the Rate Gap
For each code, calculate the difference between your current rate and a target benchmark (we recommend the 25th percentile for your metro). Multiply by annual volume. This produces a dollar figure that represents your addressable savings opportunity — not a theoretical estimate, but arithmetic based on your actual claims and actual market rates.
For nerve blocks alone, an employer with 100 orthopedic surgeries per year might find $50,000-$150,000 in rate gap between their current pricing and the 25th percentile.
Step 4: Negotiate with Specificity
The traditional renewal conversation goes: "We need a better discount." The data-informed conversation goes: "Our plan is paying $2,700 for CPT 64446 at Memorial Hermann. The Houston market 25th percentile is $1,100. Centene has negotiated $948 at the same facility. We need our rate at or below $1,200."
This is a fundamentally different negotiation. It is specific, verifiable, and grounded in market data. The TPA or payer cannot deflect with aggregate discount statistics because the conversation is about specific rates at specific facilities.
Step 5: Build Ongoing Monitoring
Rate benchmarking is not a one-time exercise. Market rates shift. Contract terms change. New facilities enter the network. The employers who sustain savings over time are those who monitor their rate positioning continuously — not just at renewal.
The Risk of Doing Nothing
Employers who continue to evaluate their healthcare costs through the lens of discount percentages face a compounding problem. As hospital chargemaster prices increase (they grow 5-8% annually in most markets), a fixed discount percentage produces higher and higher actual payments. A 55% discount that seemed adequate three years ago may now yield rates in the 75th or 90th percentile of the market.
Meanwhile, the employers who have shifted to rate-based benchmarking are systematically driving their costs toward the lower quartile. The gap between these two groups widens every year.
Implications for Brokers and Consultants
Benefits consultants and brokers who bring rate-level intelligence to their employer clients create a form of value that is difficult to replicate. Any broker can negotiate a discount percentage. Very few can walk into a meeting and say: "Here is exactly what your plan is paying for the 50 highest-cost procedures, benchmarked against every major payer in Houston, with a specific dollar figure for your savings opportunity."
This is the difference between a transactional broker relationship and an advisory one. The data to support this shift now exists. The question is who will use it first.
The Bottom Line
The Houston nerve block data illustrates a simple truth: discount percentages are vanity metrics. They measure the distance between an arbitrary starting point and an unknown fair price. They create the illusion of value while obscuring the actual cost.
Rate-level benchmarking — comparing what your plan actually pays against what the market actually charges — is the only metric that tells you whether your healthcare spend is competitive. For surgical nerve blocks in Houston, the data shows a 3x spread between the highest and lowest payer medians. That gap is your opportunity.
The information is available. The analysis is straightforward. The savings are material. What remains is the decision to look.
See how these findings apply to your plan.
We run this analysis on actual claims data for self-insured employers. Your dedicated partner delivers these insights every month.